Logo image of KDLY

KINDLY MD INC (KDLY) Stock Fundamental Analysis

NASDAQ:KDLY - Nasdaq - US49457M1062 - Common Stock - Currency: USD

3.28  +1.86 (+130.73%)

After market: 2.88 -0.4 (-12.2%)

Fundamental Rating

2

Taking everything into account, KDLY scores 2 out of 10 in our fundamental rating. KDLY was compared to 109 industry peers in the Health Care Providers & Services industry. KDLY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. KDLY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

KDLY had negative earnings in the past year.
In the past year KDLY has reported a negative cash flow from operations.
KDLY Yearly Net Income VS EBIT VS OCF VS FCFKDLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

With a Return On Assets value of -68.01%, KDLY is not doing good in the industry: 90.74% of the companies in the same industry are doing better.
KDLY's Return On Equity of -84.41% is on the low side compared to the rest of the industry. KDLY is outperformed by 76.85% of its industry peers.
Industry RankSector Rank
ROA -68.01%
ROE -84.41%
ROIC N/A
ROA(3y)-127.35%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KDLY Yearly ROA, ROE, ROICKDLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 500 -500 1K

1.3 Margins

The Gross Margin of KDLY (93.90%) is better than 99.07% of its industry peers.
KDLY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 93.9%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KDLY Yearly Profit, Operating, Gross MarginsKDLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 50 -50

More info and screens

6

2. Health

2.1 Basic Checks

KDLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KDLY has about the same amount of shares outstanding.
KDLY has a worse debt/assets ratio than last year.
KDLY Yearly Shares OutstandingKDLY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 1M 2M 3M 4M 5M
KDLY Yearly Total Debt VS Total AssetsKDLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 200K 400K 600K 800K 1M

2.2 Solvency

KDLY has an Altman-Z score of 3.40. This indicates that KDLY is financially healthy and has little risk of bankruptcy at the moment.
KDLY has a better Altman-Z score (3.40) than 72.22% of its industry peers.
KDLY has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.00, KDLY belongs to the best of the industry, outperforming 85.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.4
ROIC/WACCN/A
WACC9.12%
KDLY Yearly LT Debt VS Equity VS FCFKDLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 200K -200K -400K

2.3 Liquidity

A Current Ratio of 5.43 indicates that KDLY has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.43, KDLY belongs to the top of the industry, outperforming 95.37% of the companies in the same industry.
A Quick Ratio of 5.43 indicates that KDLY has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.43, KDLY belongs to the top of the industry, outperforming 95.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.43
Quick Ratio 5.43
KDLY Yearly Current Assets VS Current LiabilitesKDLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 200K 400K 600K 800K

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.33% over the past year.
KDLY shows a decrease in Revenue. In the last year, the revenue decreased by -0.49%.
EPS 1Y (TTM)36.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97.75%
Revenue 1Y (TTM)-0.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-25.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KDLY Yearly Revenue VS EstimatesKDLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 1M 2M 3M
KDLY Yearly EPS VS EstimatesKDLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KDLY. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KDLY Price Earnings VS Forward Price EarningsKDLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KDLY Per share dataKDLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KDLY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KINDLY MD INC

NASDAQ:KDLY (2/12/2025, 8:23:29 PM)

After market: 2.88 -0.4 (-12.2%)

3.28

+1.86 (+130.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.86%
Inst Owner Change-2.71%
Ins Owners2.22%
Ins Owner Change0.38%
Market Cap19.52M
AnalystsN/A
Price TargetN/A
Short Float %3.58%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.79
P/FCF N/A
P/OCF N/A
P/B 5.6
P/tB 5.6
EV/EBITDA N/A
EPS(TTM)-0.55
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.4
OCFYN/A
SpS0.48
BVpS0.59
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -68.01%
ROE -84.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 93.9%
FCFM N/A
ROA(3y)-127.35%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.76%
Cap/Sales 0.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.43
Quick Ratio 5.43
Altman-Z 3.4
F-Score4
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)638.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.77%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-97.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.49%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-25.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-220.19%
OCF growth 3YN/A
OCF growth 5YN/A